» Articles » PMID: 26797458

Organoid Culture Systems for Prostate Epithelial and Cancer Tissue

Overview
Journal Nat Protoc
Specialties Biology
Pathology
Science
Date 2016 Jan 23
PMID 26797458
Citations 345
Authors
Affiliations
Soon will be listed here.
Abstract

This protocol describes a strategy for the generation of 3D prostate organoid cultures from healthy mouse and human prostate cells (either bulk or FACS-sorted single luminal and basal cells), metastatic prostate cancer lesions and circulating tumor cells. Organoids derived from healthy material contain the differentiated luminal and basal cell types, whereas organoids derived from prostate cancer tissue mimic the histology of the tumor. We explain how to establish these cultures in the fully defined serum-free conditioned medium that is required to sustain organoid growth. Starting with the plating of digested tissue material, full-grown organoids can usually be obtained in ∼2 weeks. The culture protocol we describe here is currently the only one that allows the growth of both the luminal and basal prostatic epithelial lineages, as well as the growth of advanced prostate cancers. Organoids established using this protocol can be used to study many different aspects of prostate biology, including homeostasis, tumorigenesis and drug discovery.

Citing Articles

Cellular Systems for Colorectal Stem Cancer Cell Research.

Grigoreva T, Kindt D, Sagaidak A, Novikova D, Tribulovich V Cells. 2025; 14(3).

PMID: 39936962 PMC: 11817814. DOI: 10.3390/cells14030170.


Mapping T cell dynamics to molecular profiles through behavior-guided transcriptomics.

Wezenaar A, Pandey U, Keramati F, Hernandez-Roca M, Brazda P, Barrera Roman M Nat Protoc. 2025; .

PMID: 39930061 DOI: 10.1038/s41596-024-01126-4.


Generation of human fetal brain organoids and their CRISPR engineering for brain tumor modeling.

Pagliaro A, Andreatta F, Finger R, Artegiani B, Hendriks D Nat Protoc. 2025; .

PMID: 39915620 DOI: 10.1038/s41596-024-01107-7.


Protocol for functional screening of CFTR-targeted genetic therapies in patient-derived organoids using DETECTOR deep-learning-based analysis.

Bulcaen M, Liu R, Gryspeert K, Thierie S, Ramalho A, Vermeulen F STAR Protoc. 2025; 6(1):103593.

PMID: 39893642 PMC: 11835653. DOI: 10.1016/j.xpro.2024.103593.


p53-loss induced prostatic epithelial cell plasticity and invasion is driven by a crosstalk with the tumor microenvironment.

Yanushko D, German Falcon B, El Bizri R, Pervizou D, Dolgos R, Keime C Cell Death Dis. 2025; 16(1):46.

PMID: 39865080 PMC: 11770131. DOI: 10.1038/s41419-025-07361-1.


References
1.
Xin L, Ide H, Kim Y, Dubey P, Witte O . In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme. Proc Natl Acad Sci U S A. 2003; 100 Suppl 1:11896-903. PMC: 304104. DOI: 10.1073/pnas.1734139100. View

2.
Kim K, Kakitani M, Zhao J, Oshima T, Tang T, Binnerts M . Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science. 2005; 309(5738):1256-9. DOI: 10.1126/science.1112521. View

3.
Xin L, Lukacs R, Lawson D, Cheng D, Witte O . Self-renewal and multilineage differentiation in vitro from murine prostate stem cells. Stem Cells. 2007; 25(11):2760-9. DOI: 10.1634/stemcells.2007-0355. View

4.
Pienta K, Abate-Shen C, Agus D, Attar R, Chung L, Greenberg N . The current state of preclinical prostate cancer animal models. Prostate. 2008; 68(6):629-39. PMC: 3681409. DOI: 10.1002/pros.20726. View

5.
Sato T, Vries R, Snippert H, van de Wetering M, Barker N, Stange D . Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009; 459(7244):262-5. DOI: 10.1038/nature07935. View